Concerns have been raised in light of anecdotal case stories of suicidality and depression that have been associated in one way or another with taking Roaccutane.
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.'s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY) (formerly AccuStem Sciences Ltd.), today announced
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication
New York, March 1, 2022 - Tiziana Life Sciences Ltd. reports that its former subsidiary, AccuStem Sciences, Inc. , today announced publication of new data in the European Journal of Cancer.. | March 1, 2022
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication